On 2024-08-14, VYNE Therapeutics Inc. (VYNE) announced earnings per share of $-0.22 for the fiscal quarter ending 2024-06-30, missing the average analyst estimate of $-0.19.
The next expected annoucement date for quarterly earnings is 2024-11-11, with an average estimated earnings per share of $-0.23 for the fiscal quarter ending 2024-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2024-08-14 | 2024-06-30 | $-0.19 | $-0.22 |
| 2024-05-09 | 2024-03-31 | $-0.24 | $-0.15 |
| 2024-02-29 | 2023-12-31 | $-0.50 | $-0.20 |
| 2023-11-13 | 2023-09-30 | $-0.76 | $-1.85 |
| 2023-08-14 | 2023-06-30 | $-1.99 | $-3.08 |
| 2023-05-11 | 2023-03-31 | $-2.50 | $-1.74 |
| 2023-03-09 | 2022-12-31 | $-3.24 | $-2.60 |
| 2022-11-10 | 2022-09-30 | $-2.88 | $-2.88 |
| 2022-08-12 | 2022-06-30 | $-3.24 | $-2.52 |
| 2022-05-12 | 2022-03-31 | $-2.88 | $-2.88 |
| 2022-03-17 | 2021-12-31 | $-3.96 | $-3.96 |
| 2021-11-10 | 2021-09-30 | $-5.94 | $-7.37 |
| 2021-08-12 | 2021-06-30 | $-6.47 | $-7.01 |
| 2021-05-06 | 2021-03-31 | $-8.63 | $-7.55 |
| 2021-03-04 | 2020-12-31 | $-9.71 | $-9.89 |
| 2020-11-05 | 2020-09-30 | $-13.67 | $-10.79 |
| 2020-08-06 | 2020-06-30 | $-15.11 | $-87.05 |
| 2020-05-11 | 2020-03-31 | $-35.97 | $-68.35 |
| 2020-03-03 | 2019-12-31 | $-59.71 | $-64.03 |
| 2019-10-31 | 2019-09-30 | $-54.68 | $-50.36 |
| 2019-08-01 | 2019-06-30 | $-60.43 | $-49.64 |
| 2019-05-02 | 2019-03-31 | $-58.27 | $-58.27 |
| 2019-02-27 | 2018-12-31 | $-56.83 | $-54.68 |
| 2018-11-07 | 2018-09-30 | $-60.43 | $-40.29 |
| 2018-08-01 | 2018-06-30 | $-57.55 | $-25.90 |
| 2018-05-09 | 2018-03-31 | $-48.92 | $-51.80 |
| 2018-03-28 | 2017-12-31 | -- | $-129.50 |